Riccardo M.
- Country
- Italy
- Department
- Division of Nephrology, Dialysis and Kidney Transplantation
Research Overview
- Long-term safety and tolerability of zigakibart in adults with primary IgA nephropathy: an open-label extension study
- Evaluation of Corticosteroids, Dapagliflozin, and RASBs on Proteinuria in IgA Nephropathy Patients with Active and Chronic Renal Lesions
- A Phase 3a Randomized Controlled Trial Comparing Metformin and Tolvaptan in Adults with Autosomal Dominant Polycystic Kidney Disease
Data & Insights
Has run more than one trial at 36 of 155 partner sites.
Specializations
Kidney Disease Management
The investigator specializes in the treatment of IgA nephropathy (IgAN), exploring innovative therapeutic approaches for patients with various stages of kidney damage. Their research encompasses both early intervention strategies and chronic condition management.
- Active renal lesions treatment
- Corticosteroid therapy optimization
- RAS blockers implementation
Their work includes evaluation of targeted therapies based on specific kidney biopsy findings.
Genetic Kidney Disorders
The investigator focuses on treating Autosomal Dominant Polycystic Kidney Disease (ADPKD), investigating alternative therapeutic approaches to manage this hereditary condition.
- Kidney function preservation
- Novel therapeutic alternatives
- Long-term disease management
Their research explores comparative effectiveness of different treatment modalities in slowing disease progression.
Innovative Therapeutics
The investigator evaluates novel therapeutic agents including SGLT2 inhibitors and metformin for kidney diseases, focusing on their potential to improve patient outcomes while minimizing treatment-related complications.
- Alternative treatment pathways
- Medication comparative studies
- Side effect reduction strategies
Their work emphasizes the development of targeted therapeutic approaches based on individual patient characteristics.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.